G1 THERAPEUTICS
G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It is also advancing rintodestrant, a potential oral selective estrogen receptor degrader, or serd, for the treatment of er+ breast cancer. It is committed to improving the lives of those impacted by cancer. It is also executing a tumor-agnostic development program, with late-stage clinical trials ongoing in multiple tumor types.
G1 THERAPEUTICS
Industry:
Biotechnology Developer Platform Medical Therapeutics
Founded:
2008-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.g1therapeutics.com
Total Employee:
101+
Status:
Active
Contact:
+1 919 213 9835
Email Addresses:
[email protected]
Total Funding:
497.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Amazon
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - G1 Therapeutics
Tavistock Life Sciences
Tavistock Life Sciences investment in Series C - G1 Therapeutics
Franklin Templeton Investments
Franklin Templeton Investments investment in Series C - G1 Therapeutics
Cowen Group
Cowen Group investment in Series C - G1 Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - G1 Therapeutics
Eshelman Ventures
Eshelman Ventures investment in Series C - G1 Therapeutics
Aju IB Investment
Aju IB Investment investment in Series C - G1 Therapeutics
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - G1 Therapeutics
Mountain Group Capital
Mountain Group Capital investment in Series C - G1 Therapeutics
Lumira Ventures
Lumira Ventures investment in Series C - G1 Therapeutics
Key Employee Changes
Official Site Inspections
http://www.g1therapeutics.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.34 K
- Host name: 98.124.224.17
- IP address: 98.124.224.17
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
